Table 8.
Physiologic Variable | Fetus | Newborn | Adult | Reference |
---|---|---|---|---|
Gqα expression (in rat portal vein, % adult value) | 400 to 500 | 100 | [448] | |
Ins (1,4,5)P3-induced contraction (% Ca2+-induced maximum) | 9±2 (35) | 26±5 | [357] | |
Ins(1,4,5)P3 Response to Norepinephrine (% of Basal) | 345±27 (97) | 355±23 | [407] | |
Ins(1,4,5)P3 ·α1-AR−1 | 5.2±1.0c (45) | 11.5±1.0 | [407] | |
Ins(1,4,5)P3-Receptor Density (fmol·mg protein−1) | 115±15 (116) | 99±5 | [449] | |
Ca2+ Mass (nmol·mg dry wt−1) | 12±2b (400) | 3±1 | [354] | |
Ca2+ Mass of Ins(1,4,5)P3-Sensitive pool | 1.6±0.2 (94) | 1.7±0.2 | [354] | |
Ca2+ Mass of Ryanodine-Sensitive Pool | 1.2±0.1b (1200) | 0.1±0.1 | [354] | |
Calcium “sparks” | Significantly less | Significantly less | Control value | [378] |
MLCK concentration (10−6M)* | 1.8±0.1b (22) | 8.2±0.6 | [450] | |
(normalized to fetal value) | 1.0 (26) | 3.8±0.7 | [451] | |
MLCK maximum velocity (ng MLC phosphorylated · ng MLCK−1)* | 1.52±0.2b (585) | 0.26±0.01 | [450] | |
MLCK In situ Fractional Activation* | 9.1±0.8b (535) | 1.7±0.2 | [450] | |
Total MLCK activity (% MLC20 phosphorylated · sec−1)* | 7.39±0.53 (89) | 6.56±0.29 | [450] | |
MLCP Concentration (normalized to fetal value) | 1.0 (56) | 1.8±0.2 | [451] | |
MLC20 concentration (10−6M)* | 236±44 (119) | 198±28 | [450] | |
Phosphorylated/Total MLC20 (% Adult Value) | (64) | 100 | [9] | |
CPI-17 – Total (% Adult Value) | (15) | 100 | [9] | |
Calmodulin concentration (10−6M)* | 12.4±1.3b (41) | 30.6±3.7 | [450] | |
(normalized to fetal value) | 1.0 (31) | 3.2±0.7 | [451] | |
HSP-27 (normalized to fetal value) | 1.0 (50) | 2.0±0.2 | [451] |
Values are mean ±SE or 5 or more in each group;
Values in parentheses represent % of adult value;
Significantly different from adult value:
P<0.01;
P<0.05;
CCA